In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens

NCT ID: NCT00584727

Last Updated: 2015-05-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric and a spherical contact lens currently available in market, specifically with regards to the fit and visual acuity as well as the comfort, vision and satisfaction while in the practitioner's office. Approximately 2 hours duration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-dispensing, single-masked (subject-masked), randomised, controlled study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

senofilcon A/alphafilcon A/etafilcon A

First intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses

Group Type ACTIVE_COMPARATOR

senofilcon A toric contact lens

Intervention Type DEVICE

contact lens

alphafilcon A toric

Intervention Type DEVICE

contact lens

etafilcon A sphere

Intervention Type DEVICE

contact lens

alphafilcon A/etafilcon A/senofilcon A

First intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses

Group Type ACTIVE_COMPARATOR

senofilcon A toric contact lens

Intervention Type DEVICE

contact lens

alphafilcon A toric

Intervention Type DEVICE

contact lens

etafilcon A sphere

Intervention Type DEVICE

contact lens

etafilcon A/senofilcon A/alphafilcon A

First intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses

Group Type ACTIVE_COMPARATOR

senofilcon A toric contact lens

Intervention Type DEVICE

contact lens

alphafilcon A toric

Intervention Type DEVICE

contact lens

etafilcon A sphere

Intervention Type DEVICE

contact lens

senofilcon A/etafilcon A/alphafilcon A

First intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses

Group Type ACTIVE_COMPARATOR

senofilcon A toric contact lens

Intervention Type DEVICE

contact lens

alphafilcon A toric

Intervention Type DEVICE

contact lens

etafilcon A sphere

Intervention Type DEVICE

contact lens

alphafilcon A/senofilcon A/etafilcon A

First intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses

Group Type ACTIVE_COMPARATOR

senofilcon A toric contact lens

Intervention Type DEVICE

contact lens

alphafilcon A toric

Intervention Type DEVICE

contact lens

etafilcon A sphere

Intervention Type DEVICE

contact lens

etafilcon A/alphafilcon A/senofilcon A

First intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses

Group Type ACTIVE_COMPARATOR

senofilcon A toric contact lens

Intervention Type DEVICE

contact lens

alphafilcon A toric

Intervention Type DEVICE

contact lens

etafilcon A sphere

Intervention Type DEVICE

contact lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

senofilcon A toric contact lens

contact lens

Intervention Type DEVICE

alphafilcon A toric

contact lens

Intervention Type DEVICE

etafilcon A sphere

contact lens

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy
3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
4. be able and willing to adhere to the instructions set forth in the protocol.
5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
8. be in good general health, based on his/her knowledge.
9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.

Exclusion Criteria

1. The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
3. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
4. Slit lamp findings that would contraindicate contact lens wear such as:

* Pathological dry eye or associated findings
* Pterygium or corneal scars within the visual axis
* Neovascularization \>1mm in from the limbus
* History of giant papillary conjunctivitis (GPC) worse than Grade 2
* Anterior uveitis or iritis (past or present)
* Seborrhoeic eczema, seborrhoeic conjunctivitis
5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
6. A known history of corneal hypoesthesia (reduced corneal sensitivity.)
7. Aphakia, keratoconus or a highly irregular cornea.
8. Current pregnancy or lactation (to the best of the subject's knowledge).
9. Active participation in another clinical study at any time during this study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foresight Regulatory Strategies, Inc.

INDUSTRY

Sponsor Role collaborator

Johnson & Johnson Vision Care, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vistakon

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jason Chin, O.D.

Role: PRINCIPAL_INVESTIGATOR

James Fujimoto, O.D.

Role: PRINCIPAL_INVESTIGATOR

Weslie Hamada, OlD.

Role: PRINCIPAL_INVESTIGATOR

Arthur T. Kobayashi, O.D., Inc.

Dennis Kuwuabara, O.D.

Role: PRINCIPAL_INVESTIGATOR

Eye Care Associates of Hawaii

Mark Nakano, O.D.

Role: PRINCIPAL_INVESTIGATOR

Mark E. Nakano Optometric Corp.

Ikuko Sugimoto, O.D.

Role: PRINCIPAL_INVESTIGATOR

Kevin Rosin, O.D.

Role: PRINCIPAL_INVESTIGATOR

Drs. Farkas, Kassalow, Resnick & Associates

Jennifer Kao, O.D.

Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR-0714A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.